Clinical Trials Directory

Trials / Suspended

SuspendedNCT03766971

Influence of Tobacco Use on Cannabis Use

Status
Suspended
Phase
Phase 2
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Cannabis smokers who also smoke tobacco cigarettes have markedly higher rates of cannabis relapse relative to those who do not use tobacco. There is a clear need to develop and evaluate interventions for dual tobacco and cannabis users. The investigators of this study have previously shown that the co-use of tobacco cigarettes contributes to the maintenance of daily cannabis use, and that age of cigarette onset is a critical predictor of treatment outcome. Short-term tobacco cessation may suffice in altering cannabis relapse rates in later-onset cigarette smokers, while a longer period of tobacco cessation may be needed for earlier-onset smokers. In the current study, a human laboratory model will be utilized to determine whether cannabis relapse varies as a function of tobacco cessation duration and age of tobacco use onset.

Conditions

Interventions

TypeNameDescription
BEHAVIORAL7 days of Tobacco CessationParticipants will be randomly assigned to 7 days of tobacco cessation.
BEHAVIORAL21 days of Tobacco CessationParticipants will be randomly assigned to 21 days of tobacco cessation.
DRUGCannabisParticipants will receive cannabis.

Timeline

Start date
2020-02-01
Primary completion
2026-11-30
Completion
2027-11-30
First posted
2018-12-06
Last updated
2025-08-17

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03766971. Inclusion in this directory is not an endorsement.